International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.

Annals of hematology

Volumn 91, Issue 1, 2012, Pages 93-102

  Yang, Sheng Hsiang ^a   Teng, Hao Wei ^b   Hong, Ying Chung ^b   Liu, Chun Yu ^b   Yu, Yuan Bin ^b   Yang, Ching Fen ^b   Gau, Jyh Pyng ^b   Liu, Jin Hwang ^b   Chang, Tai Jay ^b   Yen, Jeffrey J Y ^b   Chen, Po Min ^b   Chiou, Tzeon Jye ^b   Tzeng, Cheng Hwai ^b   Hsiao, Liang Tsai ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; THALIDOMIDE;

ADULT; AGED; ARTICLE; ASIAN; CANCER STAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; THALIDOMIDE;

EID: 84863126034     PISSN: None     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1251-y     Document Type: Article

References (0)